| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8714691 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 12 Pages |
Abstract
The pooled analysis in 1,514 subjects from 8 clinical studies demonstrates that the 5-grass pollen sublingual tablet has a similar good safety profile in adult and pediatric patients with or without mild, intermittent asthma.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Thomas B. MD, Linda S. MD, Ulrich MD, David B.K. MD, Brigitte MD, Alain MD,